67598 Federal Register / Vol. 69, No. 222 / Thursday, November 18, 2004 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Dennis Leszczynski, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6170, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1044, leszczyd@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel RPHB–B 

(04): Factors in Pulmonary Health. 

Date: November 18, 2004. 

Time: 1:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Karen Lechter, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3128, 

MSC 7759, Bethesda, MD 20892, (301) 496–

0726, lechterk@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Bacterial 

Transport. 

Date: November 19, 2004. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Diane L. Stassi, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3202, 

MSC 7808, Bethesda, MD 20892, (301) 435–

2514, stassid@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflicts in Affect and Cognition. 

Date: November 22, 2004.

Time: 4 p.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Luci Roberts, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3188, 

MSC 7848, Bethesda, MD 20892, (301) 435–

0692, roberlu@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Human 

Circadian Rhythms and Sleep. 

Date: November 30, 2004. 

Time: 11:30 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Richard Marcus, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5168, 

MSC 7844, Bethesda, MD 20892, (301) 435–

1245, marcusr@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 SSS U 

03:Member Conflict BDPE. 

Date: December 2, 2004. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Marcia Steinberg, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5130, 

MSC 7840, Bethesda, MD 20892, (301) 435–

1023, steinbem@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Host 

Immunity in Candida Pathogenesis. 

Date: December 3, 2004. 

Time: 2 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Melody Mills, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3204, 

MSC 7808, Bethesda, MD 20892, (301) 435–

0903, millsm@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Pathophysiological Role of Adenylyl Cyclas 

Isoforms. 

Date: December 3, 2004. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Anshumali Chaudhari, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4124, 

MSC 7802, Bethesda, MD 20892, (301) 435–

1210, chaudhaa@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Craniofacial 

Development. 

Date: December 8, 2004. 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Priscilla B. Chen, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4104, 

MSC 7814, Bethesda, MD 20892, (301) 435–

1787, chenp@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Etiology and 

Burkitt’s Lymphoma. 

Date: December 21, 2004. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: John C. Pugh, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7808, Bethesda, MD 20892, (301) 435–

2398, pughjohn@csr.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.393–93.396, 93.837–93.844, 93.846–

93.878, 93.892, 93.893, National Institutes of 

Health, HHS)

Dated: November 10, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–25571 Filed 11–17–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel TCR Gene 

Rearrangement. 

Date: November 15, 2004. 

Time: 11:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Federal Register / Vol. 69, No. 222 / Thursday, November 18, 2004 / Notices 67599

Contact Person: Betty Hayden, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4206, 

MSC 7812, Bethesda, MD 20892, 301–435–

1223, haydenb@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Anaplasma 

Regulation of Granulocytes. 

Date: November 29, 2004. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Richard G. Kostriken, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3184, 

MSC 7808, Bethesda, MD 20892, 301–402–

4454, kostrikr@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Protein 

Structure and Function. 

Date: December 1, 2004. 

Time: 1:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Richard Panniers, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2212, 

MSC 7890, Bethesda, MD 20892, (301) 435–

1741, pannierr@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel 

Immunobiology of Human Basophils. 

Date: December 8, 2004.

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Samuel C. Edwards, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4200, 

MSC 7812, Bethesda, MD 20892, 301–435–

1152, edwardss@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Inactivation 

of Prions. 

Date: December 8, 2004. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Richard G. Kostriken, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3184, 

MSC 7808, Bethesda, MD 20892, 301–402–

4454, kostrikr@csr.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS)

Dated: November 10, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–25572 Filed 11–17–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration will publish 

periodic summaries of proposed 

projects. To request more information 

on the proposed projects or to obtain a 

copy of the information collection 

plans, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: Access to Recovery 

(ATR) Program—New 

In preparation for implementing 

Performance Partnership Grants, 

SAMHSA has developed a set of 

performance outcome measures for 

substance abuse treatment that cover 

seven domains. The domains are: 

Abstinence from drug use and alcohol 

abuse, or decreased mental illness 

symptomatology; increased or retained 

employment and school enrollment; 

decreased involvement with the 

criminal justice system; increased 

stability in family and living conditions; 

increased access to services; increased 

retention in services for substance abuse 

treatment or decreased utilization of 

psychiatric inpatient beds for mental 

health treatment; and increased social 

connectedness to family, friends, coworkers and classmates. 

SAMHSA’s Center for Substance 

Abuse Treatment (CSAT), is responsible 

for implementing the new Access to 

Recovery (ATR) grant program. States 

funded in the ATR program will use 

these outcome measures to meet the 

reporting requirements of the 

Government Performance and Results 

Act (GPRA) by quantifying the effects 

and accomplishments of the funded 

programs. The ATR Program is part of 

a Presidential initiative to: (1) Provide 

client choice among substance abuse 

clinical treatment and recovery support 

service providers, (2) expand access to 

a comprehensive array of clinical 

treatment and recovery support options 

(including faith-based programmatic 

options), and (3) increase substance 

abuse treatment capacity. Monitoring 

outcomes, tracking costs, and 

preventing waste, fraud and abuse to 

ensure accountability and effectiveness 

in the use of Federal funds are also 

important elements of the ATR program. 

Grantees, as a contingency of their 

award, are responsible for collecting 

data from their clients at intake, 

discharge, at 30 days after intake, and 

every two months during an episode of 

care. An episode of care is defined as a 

client’s entry to and exit from the ATR. 

The following tables summarize the 

annual response burden for the ATR 

activities using the performance 

outcome measures.